With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Determining Social Risk Factors for Poor Outcomes in Pediatric Cancer Using Children’s Oncology Group Registries||University of Utah / Anne Kirchhoff, PhD/MPH||Epidemiology Grants||2019||Utah|
|Preclinical Development of a First-in-Class PCNA Inhibitor for Treating Neuroblastoma||City of Hope National Medical Center / Linda Malkas, PhD||Reach Grants||2019||California|
|Targeting microenvironment-induced TGFB signaling to overcome drug resistance in acute lymphoblastic leukemia||St. Jude Children's Research Hospital / Charles Mullighan, MD||Innovation Grants||2019||Tennessee|
|Cancer Risk and Incidence in Beckwith-Wiedemann Syndrome||Children's Hospital of Philadelphia / Jennifer Kalish, MD/PhD||Epidemiology Grants||2019||Pennsylvania|
|Norepinephrine Transporter-Targeted Pharmacotherapy of Aggressive Neuroblastoma||Children's Hospital of Philadelphia / Michael Chorny, PhD||Innovation Grants||2019||Pennsylvania|
|Therapeutic Targets and Molecular Mechanisms in Childhood Brainstem Tumors||University Health Network - Toronto Western Research Institute / Jerome Fortin, PhD||Young Investigator Grants||2019||Ontario|
|Therapeutic Targeting of the Disrupted Metabolic State in DIPG||University of Michigan / Costas Lyssiotis, PhD & Sriram Venneti, MD/PhD||Innovation Grants||2019||Michigan|
|The anti-tumor immune microenvironment in the Sonic Hedgehog subclass of medulloblastoma||Emory University / Anna Kenney, PhD||Innovation Grants||2019||Georgia|
|Bcl2-Family Inhibitors in Neuroblastoma: Mechanism of Action, Therapy Resistance, and Development of Biomarkers||Children's Hospital of Philadelphia / Claudia Zapata, MD||Young Investigator Grants||2019||Pennsylvania|
|Targeting mechanisms of Siglec15-mediated immune evasion in hematologic malignancies||Emory University / Christopher Porter, MD||Innovation Grants||2019||Georgia|